These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10869738)

  • 21. Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial.
    Hau E; Browne LH; Khanna S; Cail S; Cert G; Chin Y; Clark C; Inder S; Szwajcer A; Graham PH
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):682-9. PubMed ID: 21255943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy.
    Berberich W; Schnabel K; Berg D; Lamprecht E
    Eur J Obstet Gynecol Reprod Biol; 2001 Feb; 94(2):276-82. PubMed ID: 11165739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.
    Kindts I; Laenen A; Christiaens M; Janssen H; Van Limbergen E; Weltens C
    Strahlenther Onkol; 2019 Jan; 195(1):21-31. PubMed ID: 30140943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.
    van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Winter J; van Zijl K
    J Natl Cancer Inst Monogr; 1992; (11):15-8. PubMed ID: 1627421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
    Poortmans P; Bartelink H; Horiot JC; Struikmans H; Van den Bogaert W; Fourquet A; Jager J; Hoogenraad W; Rodrigus P; Wárlám-Rodenhuis C; Collette L; Pierart M;
    Radiother Oncol; 2004 Jul; 72(1):25-33. PubMed ID: 15236871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors.
    Hille-Betz U; Vaske B; Bremer M; Soergel P; Kundu S; Klapdor R; Hillemanns P; Henkenberens C
    Strahlenther Onkol; 2016 Jan; 192(1):8-16. PubMed ID: 26416291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Search of a Gold Standard Scoring System for the Subjective Evaluation of Cosmetic Outcomes Following Breast-Conserving Therapy.
    Racz JM; Hong NL; Latosinsky S
    Breast J; 2015; 21(4):345-51. PubMed ID: 25940058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy.
    Wazer DE; Kramer B; Schmid C; Ruthazer R; Ulin K; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):381-93. PubMed ID: 9308942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer.
    Johansen J; Overgaard J; Rose C; Engelholm SA; Gadeberg CC; Kjaer M; Kamby C; Juul-Christensen J; Blichert-Toft M; Overgaard M;
    Acta Oncol; 2002; 41(4):369-80. PubMed ID: 12234030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cosmetic outcome in early breast cancer treated with breast conservation.
    Al-Ghazal SK; Blamey RW; Stewart J; Morgan AA
    Eur J Surg Oncol; 1999 Dec; 25(6):566-70. PubMed ID: 10556000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.
    Immink JM; Putter H; Bartelink H; Cardoso JS; Cardoso MJ; van der Hulst-Vijgen MHV; Noordijk EM; Poortmans PM; Rodenhuis CC; Struikmans H
    Ann Oncol; 2012 Oct; 23(10):2591-2598. PubMed ID: 22499858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cosmetic results of breast conserving therapy for breast carcinoma. Treatment results from the Heidelberg Radiation Clinic in the years 1984 to 1992].
    Maessen D; Flentje M; Weischedel U
    Strahlenther Onkol; 1998 May; 174(5):251-6. PubMed ID: 9614953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncoplastic versus conventional breast conserving surgery. A comparison of clinicopathological findings, cosmetic results and quality of life in 60 cases].
    Mátrai Z; Gulyás G; Kovács E; Sándor Z; Polgár C; Bartal A; Kásler M
    Magy Onkol; 2014 Jun; 58(2):116-27. PubMed ID: 25010760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer.
    Sarin R; Dinshaw KA; Shrivastava SK; Sharma V; Deore SM
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):285-92. PubMed ID: 8407402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
    Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.